Biden Administration To Send Pharma Companies Opening Offers For Medicare Program’s First Ever Drug Price Negotiations



Under the Inflation Reduction Act, Medicare is poised to send initial offers to manufacturers of the first ten drugs chosen for negotiation, challenging the established prices set by pharmaceutical companies

This historic initiative aims to alleviate the financial burden on seniors, who, in 2022, spent an estimated $3.4 billion out-of-pocket for these crucial medications

The program directly confronts the prevailing trend where drug prices in the U.S. are two to three times higher than in comparable OECD countries.

A newly released report exposes Big Pharma’s pricing practices, revealing that Americans were charged two …

Full story available on


Leave a Reply

Your email address will not be published. Required fields are marked *